Evofem Bio.sciences, Inc. acquired Womens Health Specialty Business of Lupin Limited for $84 million.
Evofem Bio.sciences, Inc. (OTCPK:EVFM) completed the acquisition of Womens Health Specialty Business of Lupin Limited (BSE:500257) on July 15, 2024
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,838 INR | +0.30% |
|
+1.37% | +38.89% |
06:01am | Lupin Sells US Commercial Women's Health Specialty Business to Evofem Biosciences | MT |
15/07 | Lupin Gets Establishment Inspection Report from US FDA After Dabhasa Unit, Inspection | MT |
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,835 INR | +0.17% | +1.24% | 999.62Cr | ||
0.0095 USD | -12.04% | -13.64% | 8L | ||
1st Jan change | Capi. | |
---|---|---|
+38.72% | 999.62Cr | |
+63.05% | 86TCr | |
+39.09% | 63TCr | |
-4.78% | 36TCr | |
+17.52% | 32TCr | |
+8.43% | 30TCr | |
+13.81% | 24TCr | |
+5.19% | 23TCr | |
+16.68% | 23TCr | |
+14.63% | 18TCr |